在结直肠癌中,NOX4通过MAPK-MEK1/2-ERK1/2轴促进瘤的进展
Yu-Jie Xu1,2, Ya-Chang Huo1, Qi-Tai Zhao1
1Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
World journal of gastrointestinal oncology
|April 25, 2024
概括
尼古丁胺胺二核酸氧化酶4 (NOX4) 促进结直肠癌 (CRC) 的进展和转移. 用特拉美丁尼布向NOX4可能为CRC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 代谢重编程在结直肠癌 (CRC) 中至关重要,但其调节者仍然不清楚.
- 了解代谢基因模式是改善CRC患者治疗结果的关键.
研究的目的:
- 调查尼古丁胺胺氨基二核酸酸氧化酶4 (NOX4) 在促进CRC进展中的作用.
- 确定NOX4作为CRC中潜在的治疗点.
主要方法:
- 在CRC中使用生物信息学和共识聚类分析了3341个代谢基因.
- 通过体外测试 (增殖,迁移,入侵,干性) 来评估CRC细胞中的NOX4功能.
- 利用mRNA测序和体内小鼠模型来评估NOX4对瘤生长和转移的影响.
主要成果:
- 在CRC组织中NOX4的表达很高,与生存率差相关.
- NOX4过度表达增强了CRC细胞的迁移,入侵和干细胞.
- NOX4激活了MAPK-MEK1/2-ERK1/2通路;特拉美替尼抑制了NOX4驱动的瘤进展和转移.
结论:
- NOX4在促进CRC转移方面发挥着重要作用.
- NOX4是CRC的潜在治疗点.
- 特拉美替尼布作为一种向NOX4.4的CRC疗法显示出前景.
相关概念视频
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


